Los Angeles Capital Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,588
Closed -$335K 1467
2025
Q1
$335K Sell
18,588
-2,460
-12% -$43.7K ﹤0.01% 857
2024
Q4
$368K Buy
21,048
+6,580
+45% +$89K ﹤0.01% 888
2024
Q3
$167K Sell
14,468
-118,913
-89% -$1.36M ﹤0.01% 1135
2024
Q2
$1.51M Sell
133,381
-33,067
-20% -$440K 0.01% 517
2024
Q1
$2.38M Sell
166,448
-14,320
-8% -$203K 0.01% 455
2023
Q4
$2.48M Buy
+180,768
New +$1.9M 0.01% 435
2021
Q2
Sell
-24,030
Closed -$330K 1696
2021
Q1
$330K Buy
+24,030
New +$373K ﹤0.01% 1405

Los Angeles Capital Management's PTVE Position: Q2 2025 in Review

Los Angeles Capital Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 18,588 shares — an estimated $335K sold.

Los Angeles Capital Management first reported a position in PTVE in Q1 2021 and held it in 7 quarters. The position peaked at $2.48M in Q4 2023. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Los Angeles Capital Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 18,588 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $335K.
  • Los Angeles Capital Management first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2021 and held it in 7 quarters.
  • Los Angeles Capital Management's Pactiv Evergreen Inc. Common stock position peaked at $2.48M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Los Angeles Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.